Medical news

ORBITA-CTO: PCI vs. Placebo in Chronic Total Occlusion Treatment

July 11, 2026Carlos Mendoza1 мин

This study, with its results presented at the ACC.26 conference, marks the first randomized, placebo-controlled trial ever conducted for this specific procedure, a context where maintaining blinding is notably challenging.